Kanser hastalarında anestezi

Kanser tedavisi almış ya da almakta olan hastalarda anestezi uygulamaları gittikçe artmaktadır. Bu hastalarda farklı nedenlerle majör organ ve sistem fonksiyonlarında değişiklikler gözlenebilmektedir. Bu değişiklikler ise anestezi uygulamasını etkileyebilir ve anestezi planının değiştirilmesine neden olabilir. Bu yazıda önceden kanser tedavisi almış ya da halen bu tedavileri almakta olan hastalarda anestezi uygulanması sırasında rastlanabilecek değişiklikler ve anestezi uygulamalarının kanser ve metastaz gelişimine etkileri hakkında güncel bilgilerin sunulması amaçlanmaktadır.

Anesthesıa for cancer patıents

The number of anesthetic procedures in patients who have received or have been receiving cancer therapy has been increasing. Some changes in major organ or system functions may be observed in these patients due to various reasons. These changes may affect and even change the planned anesthesia procedure. The aim of this report is to present the up-to-date data about the possible changes in the anesthesia plan in patients who have received or have been receiving cancer therapy and the possible effects of anesthesia on the development of cancer and metastasis.

PDF

___

1.Arain, MR, Buggy DJ. Anaesthesia for cancer patients. Curr Opin Anaesthesiol 2007; 20: 247-253.
2.Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 2012; 109 Suppl 1: i17-i28.
3. Ali Ayhan, Polat Dursun, Çağatay Taşkıran, Murat Gültekin. Bölüm 124 Jinekolojik Onkoloji Cerrahisinde Anestezi. In: Jinekolojik Onkoloji. 1. Baskı. Ankara: Güneş Kitabevi; 2012, 1015-1019.
4. A. Murat Tuncer, Nejat Özgül, Emire Olcayto, Murat Gültekin. Bölüm 1.2 Kanserin Ülkemiz ve Dünyadaki Önemi, Hastalık Yükü ve Kanser Kontrol Politikaları ve Türkiyede Kanser nsidansı. In:Türkiye'de Kanser Kontrolü. 1. Baskı. Ankara: T.C. Sağlık Bakanlğı;2009, 5-7 ve 35-50.
5. Borde D, Gandhe U, Hargave N, Pandey K. Management of patients with hematological malignancies undergoing coronary artery bypass grafting. Ann Card Anaesth 2013; 16: 47-50.
6.Huettemann E, Sakka SG. Anaesthesia and anti-cancer chemotherapeutic drugs. Curr Opin Anaesthesiol 2005; 18: 307-314.
7.Hines RL, Marschall KE. Stoelting's Anesthesia and Co-Existing Disease, 5th ed. Philadelphia:Elsevier; 2008, Chapter 20.
8.Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-664.
9. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110: 1636-1643.
10. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001; 94: 1066-1073.
11. Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237-1250.
12. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-115.
13. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008; 109: 180-187.
14. Kennedy BC, Hall GM. Neuroendocrine and inflammatory aspects of surgery: do they affect outcome? Acta Anaesthesiol Belg 1999; 50: 205-209.
15. Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007; 106: 499-506.
16. Ferguson RJ, Ahles TA. Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 2003; 3: 215-222.
17. Kiyomiya K, Matsuo S, Kurebe M. Differences in intracellular sites of action of Adriamycin in neoplastic and normal differentiated cells. Cancer Chemother Pharmacol 2001; 47: 51-56.
18. Burrows FA, Hickey PR, Colan S. Perioperative complications in patients with anthracycline chemotherapeutic agents. Can Anaesth Soc J 1985; 32: 149-157.
19. Hay JG, Haslam PL, Dewar A, Addis B, Turner-Warwick M, Laurent GJ. Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. Thorax 1987; 42: 374-382.
20. Sogal RN, Gottlieb AA, Boutros AR, et al. Effect of oxygen on bleomycin-induced lung damage. Cleve Clin J Med 1987; 54: 503-509.
21. Ingrassia TS 3rd, Ryu JH, Trastek VF, Rosenow EC 3rd. Oxygen- exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 1991; 66: 173-178.
22. Goldiner PL, Schweizer O. The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 1979; 6: 121-124.
23. Cersosimo RJ. Cisplatin neurotoxicity. Cancer Treat Rev 1989; 16: 195-211.
24. Hebl JR, Horlocker TT, Pritchard DJ. Diffuse brachial plexopathy after interscalene blockade in a patient receiving cisplatin chemotherapy: the pharmacologic double crush syndrome. Anesth Analg 2001; 92: 249-251.
25. Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997; 156: 1669-1678.
26. Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 1993; 94: 133-139.
27. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol 2004; 5: 489-496.
28. Coveney E, Weltz CR, Greengrass R, et al. Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg 1998; 227: 496-501.
29. Covelli V, Maffione AB, Nacci C, Tatò E, Jirillo E. Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines. Immunopharmacol Immunotoxicol 1998; 20: 199-209.
30. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-259.
31. Wilcock A, Twycross R. Midazolam for intractable hiccup. J Pain Symptom Manage 1996; 12: 59-61.
32. Borgeat A, Wilder-Smith OH, Wilder-Smith CH, Forni M, Suter PM. Propofol improves patient comfort during cisplatin chemotherapy. A pilot study. Oncology 1993; 50: 456-459.
33. Tsang RW, Solow HL, Ananthanarayan C, Haley S. Daily general anaesthesia for radiotherapy in unco-operative patients: ingredients for successful management. Clin Oncol (R Coll Radiol) 2001; 13: 416-421.
34. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97: 1331-1339.
35. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004; 11: 255-260.
36. Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002; 62: 4491-4498.
37. Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 2011; 112: 558-567.
38. Brand JM, Kirchner H, Poppe C, Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 1997; 83: 190-194.
39. Proceedings of the 7th International Cancer Vaccine Symposium, September 9-11, 2012, Florence, Italy. Ann N Y Acad Sci 2013; 1284: 1-86.
40. Fleischmann E, Marschalek C, Schlemitz K, et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 2009; 9: 1.
41. Kennedy KA, Hait WN, Lazo JS. Chemical modulation of bleomycin induced toxicity. Int J Radiat Oncol Biol Phys 1986; 12: 1367-1370.
42. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008; 107: 325-332.
43. Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 2000; 10: 165-169.
44. de Oliveira GS Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 2011; 36: 271-277.
45. Moslemi-Kebria M, El-Nashar SA, Aletti GD, Cliby WA. Intraoperative hypothermia during cytoreductive surgery for ovarian cancer and perioperative morbidity. Obstet Gynecol 2012; 119: 590-596.
46. Ng T, Ryder BA, Chern H, et al. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg 2012; 143: 815-819.